Morgan Hill, CA – Mitre Medical Corp. is announcing the opening of two additional clinical investigational sites – Robert Wood Johnson University Hospital (RWJUH) and Piedmont Heart. The Mitral Touch is the company’s proprietary implant that treats the cause — ventricular enlargement, and the symptom — functional mitral valve regurgitation in surgical patients at risk … Read more
Mitre Medical Corp CEO John MacMahon tells Proactive the privately-held group is developing a less invasive and safer approach to treat functional mitral valve regurgitation (MR) in patients with moderate to severe MR. MacMahon says the group recently announced one-year results of the group’s Mitral Touch in European patients, and looks forward to bringing the technology … Read more
Results Set the Stage for an Upcoming US Trial January 6, 2021 – Morgan Hill, CA – Mitre Medical Corp., (“Mitre” or “company”) an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional/secondary mitral valve regurgitation (FMR) and remodel the left ventricle (LV), announced the publication of … Read more
October 12, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV). Mitre is pleased to announce that the company will be presenting at … Read more
Advances Regulatory Strategy for the Mitral Touch in US and Japan October 9, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV). The … Read more
September 10, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV). Mitre has appointed MedMarket Access, LLC (“MedMarket Access”) to support the company’s … Read more
August 27, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre Medical” or “company”), an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR, has retained Zimmons International Communications, Inc. … Read more
The Mitral Touch Empowers Surgeons to Treat Functional MR on a Beating Heart Mitre Medical is pleased to announce concurrent to the PCR-London Valves Conference that the FDA has determined Mitre Medical Corp. has provided sufficient data to support initiation of a human clinical study to evaluate the safety and performance of the Mitral Touch … Read more
New AI-based CT Imaging Helps Screen and Assess Patients for the Mitral Touch Epicardial Clip Mitre Medical Corp. and Laralab UG have partnered to provide surgeons with the most advanced 3D epicardial models ever made prior to surgery. This software has also provided the assessment of the Mitral Touch’s performance in heart failure patients in … Read more
The Mitral Touch Represents a Breakthrough in the Surgical Treatment of Heart Failure The Mitral Touch is an epicardial clip designed to reduce mitral regurgitation and provide subvalvular support of the left ventricle for functional mitral regurgitation (FMR) patients. The ENRAPT-MR study investigated the safety and performance of the Mitral Touch during concomitant treatment of … Read more